vimarsana.com
Home
Live Updates
Oncolytics Biotech Inc.: Oncolytics Biotech Announces the Pr
Oncolytics Biotech Inc.: Oncolytics Biotech Announces the Pr
Oncolytics Biotech Inc.: Oncolytics Biotech Announces the Presentation of Preclinical Data Demonstrating the Synergistic Anti-Leukemic Effects of Pelareorep Combined with Azacitidine at the 2021 American Society of Hematology Annual Meeting
- Treatment with intravenous pelareorep plus azacitidine reduced tumor burden - Treatment with pelareorep and azacitidine dramatically upregulated multiple genes known to drive anti-cancer
Related Keywords
Georgia ,
United States ,
Canada ,
Atlanta ,
American ,
Canadian ,
Jon Patton ,
Timothy Mccarthy ,
Thomas Heineman ,
American Society Of Hematology ,
Oncolytics Biotech Inc ,
Company Contact ,
Securities Exchange ,
Global Head Of Clinical Development ,
Nasdaq ,
Annual Meeting ,
Global Head ,
Clinical Development ,
Anti Leukemic Activity ,
Securities Exchange Act ,
Oncolytics ,
Biotech ,
Nnounces ,
Presentation ,
Reclinical ,
Data ,
Emonstrating ,
Synergistic ,
Anti ,
Eukemic ,
Effects ,
Pelareorep ,
Combined ,
Azacitidine ,
021 ,
Society ,
Hematology ,
Nnual ,
The ,